DOPAMINE-RECEPTORS IN THE BASAL GANGLIA - RELEVANCE TO PARKINSONS-DISEASE

被引：70

作者：

STRANGE, PG

机构：

[1] Biological Laboratory, The University, Canterbury, Kent

来源：

MOVEMENT DISORDERS | 1993年 / 8卷 / 03期

关键词：

DOPAMINE RECEPTORS; PARKINSONS DISEASE; DRUG TREATMENT; NEOSTRIATUM; MOTOR CONTROL;

D O I：

10.1002/mds.870080303

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

At least five receptors for dopamine (D1-D5) have been recognised from molecular biological studies, and their pharmacological properties and brain localisations have been determined. The D1 and D2 subtypes are the principal subtypes in brain, and their cellular localisations in the caudate nucleus and putamen have been determined. With recent advances in the understanding of basal ganglia neuronal function, these localisation data enable insights into the mode of action of drugs used at present and in the future to treat Parkinson's disease.

引用

收藏

页码：263 / 270

页数：8

相关论文

共 55 条

[31] LOWER EFFICACY OF THE DOPAMINE-D1 AGONIST, SKF-38393, TO STIMULATE ADENYLYL CYCLASE ACTIVITY IN PRIMATE THAN IN RODENT STRIATUM [J].

PIFL, C ;

REITHER, H ;

HORNYKIEWICZ, O .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 202 (02) :273-276

[32]

PLAYFORD ED, 1992, CEREBROVAS BRAIN MET, V4, P144

[33] TURNING BEHAVIOR IN ANIMALS [J].

PYCOCK, CJ .

NEUROSCIENCE, 1980, 5 (03) :461-+

[34] PET DEMONSTRATES DIFFERENT BEHAVIOR OF STRIATAL DOPAMINE D-1 AND D-2 RECEPTORS IN EARLY PARKINSONS-DISEASE [J].

RINNE, JO ;

LAIHINEN, A ;

NAGREN, K ;

BERGMAN, J ;

SOLIN, O ;

HAAPARANTA, M ;

RUOTSALAINEN, U ;

RINNE, UK .

JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 27 (04) :494-499

[35] A POSTMORTEM STUDY ON STRIATAL DOPAMINE-RECEPTORS IN PARKINSONS-DISEASE [J].

RINNE, JO ;

LAIHINEN, A ;

LONNBERG, P ;

MARJAMAKI, P ;

RINNE, UK .

BRAIN RESEARCH, 1991, 556 (01) :117-122

[36] D1 AND D2 DOPAMINE-RECEPTORS DIFFERENTIALLY REGULATE C-FOS EXPRESSION IN STRIATONIGRAL AND STRIATOPALLIDAL NEURONS [J].

ROBERTSON, GS ;

VINCENT, SR ;

FIBIGER, HC .

NEUROSCIENCE, 1992, 49 (02) :285-296

[37] DOPAMINE RECEPTOR INTERACTIONS - SOME IMPLICATIONS FOR THE TREATMENT OF PARKINSONS-DISEASE [J].

ROBERTSON, HA .

TRENDS IN NEUROSCIENCES, 1992, 15 (06) :201-206

[38] EFFECTS OF CHRONIC TREATMENT OF MPTP MONKEYS WITH BROMOCRIPTINE ALONE OR IN COMBINATION WITH SKF 38393 [J].

ROUILLARD, C ;

BEDARD, PJ ;

DIPAOLO, T .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 185 (2-3) :209-215

[39] WEAK ANTIPARKINSONIAN ACTIVITY OF THE D1 AGONIST C-APB (SKF 82958) AND LACK OF SYNERGISM WITH A D2 AGONIST IN PRIMATES [J].

RUPNIAK, NMJ ;

BOYCE, S ;

STEVENTON, M ;

IVERSEN, SD .

CLINICAL NEUROPHARMACOLOGY, 1992, 15 (04) :307-309

[40]

SCHULTZ W, 1983, EXP BRAIN RES, V51, P377

← 1 2 3 4 5 6 →